S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)
S&P 500   4,579.50 (+0.66%)
DOW   36,088.76 (+0.10%)
QQQ   389.47 (+1.15%)
AAPL   194.72 (+1.25%)
MSFT   368.14 (-0.18%)
META   323.78 (+1.99%)
GOOGL   136.76 (+5.18%)
AMZN   146.74 (+1.54%)
TSLA   242.19 (+1.18%)
NVDA   462.85 (+1.72%)
NIO   7.60 (-1.94%)
BABA   72.27 (+1.09%)
AMD   125.14 (+7.12%)
T   17.04 (+0.59%)
F   10.84 (+1.40%)
MU   73.82 (+0.94%)
CGC   0.71 (+1.73%)
GE   118.80 (-0.84%)
DIS   93.31 (+1.98%)
AMC   6.89 (+1.47%)
PFE   28.61 (-0.63%)
PYPL   58.92 (-1.02%)
XOM   99.96 (+0.86%)

Evaxion Biotech A/S (EVAX) Stock Forecast & Price Target

$0.65
-0.03 (-5.03%)
(As of 10:36 AM ET)
Compare
Today's Range
$0.62
$0.68
50-Day Range
$0.62
$1.17
52-Week Range
$0.47
$2.28
Volume
20,298 shs
Average Volume
273,762 shs
Market Capitalization
$18.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Evaxion Biotech A/S Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

$7.00
983.93% Upside
High Forecast$7.00
Average Forecast$7.00
Low Forecast$7.00
TypeCurrent Forecast
12/7/22 to 12/7/23
1 Month Ago
11/7/22 to 11/7/23
3 Months Ago
9/8/22 to 9/8/23
1 Year Ago
12/7/21 to 12/7/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.00$9.00$9.00$11.00
Predicted Upside983.93% Upside443.81% Upside443.81% Upside397.74% Upside
Get Evaxion Biotech A/S Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.


EVAX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EVAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Evaxion Biotech A/S Stock vs. The Competition

TypeEvaxion Biotech A/SMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside929.41% Upside652.22% Upside2,089.55% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/31/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$18.00 ➝ $7.00+536.36%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:15 AM ET.












EVAX Price Target - Frequently Asked Questions

What is Evaxion Biotech A/S's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Evaxion Biotech A/S stock is Buy based on the current 1 buy rating for EVAX. The average twelve-month price prediction for Evaxion Biotech A/S is $7.00 with a high price target of $7.00 and a low price target of $7.00. Learn more on EVAX's analyst rating history.

Do Wall Street analysts like Evaxion Biotech A/S more than its competitors?

Analysts like Evaxion Biotech A/S more than other Medical companies. The consensus rating for Evaxion Biotech A/S is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how EVAX compares to other companies.

Does Evaxion Biotech A/S's stock price have much upside?

According to analysts, Evaxion Biotech A/S's stock has a predicted upside of 536.36% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

This page (NASDAQ:EVAX) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -